Impact of prosthesis oversizing on clinical outcomes of transcatheter aortic valve implantation using a self-expandable Evolut R valve

The Egyptian Heart Journal

Table 3 Showing the descriptive data of operative and postoperative parameters

Operative data		No. = 143
DI (mm)	Median (IQR)	3.1 (2.3–4.85)
	Range	1–8
DI I (mm/m²)	Median (IQR)	1.69 (1.25–2.43)
	Range	0.42–4.6
Pre- implantation Dilatation	No	107 (74.8%)
	Yes	36 (25.2%)
Post implantation-Dilatation	No	118 (82.5%)
	Yes	25 (17.5%)
DIMS %	Median (IQR)	36.14 (24.62–59.62)
	Range	10–114.23

ECG post operative		No.	%
Conduction disturbance	No	113	79.0%
	Yes	30	21.0%
Permanent CHB	No	141	98.6%
	Yes	2	1.4%
Transient conduction. Disturbance	No	132	92.3%
	Yes	11	7.7%
New LBBB	No	119	83.2%
	Yes	24	16.8%
QRS widening	No	114	79.7%
	Yes	29	20.3%
PR Prolongation	No	137	95.8%
	Yes	6	4.2%
New onset AF	No	140	97.9%
	Yes	3	2.1%

Postoperative data		No. = 143
DIDO %	Mean ± SD	16.55 ± 5.93
	Range	0–30
PVL	No (0)	61 (42.7%)
	Trivial (1)	68 (47.6%)
	Mild (2)	12 (8.4%)
	Moderate ( 3)	2 (1.4%)
	Severe (4)	0 (0.0%)
Coronary obstruction or annular rupture	No	143 (100.0%)

AF Atrial fibrillation, CHB Complete heart block, DI Depth of implantation, DIi Depth of implantation indexed, DIMS Depth of implantation to membranous septum ratio, LBBB Left bundle branch block, DIDO Depth of implantation derived oversizing index, PVR Para-valvular leakage